相关实验视频

Updated: Sep 9, 2025

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

8-OXO-Cordycepin不是适合氨酸脱氨酶的基质-初步实验和理论研究

Boleslaw T Karwowski¹

¹Nucleic Acids Damage Laboratory, Faculty of Pharmacy, Medical University of Lodz, ul. Muszynskiego 1, 90-151 Lodz, Poland.

Molecules (Basel, Switzerland)

|August 28, 2025

概括

一种新的氧化形式的Cordycepin (CordOXO) 显示对腺脱氨酶 (ADA) 的耐药性,可能增强其抗癌作用而不需要ADA抑制剂. 这一发现可能会带来更好的癌症疗法,

科学领域:

生物化学
药理学
医学化学

背景情况:

腺除氨酶 (ADA) 调节核酸代谢并使腺类药物失活.
3'- 脱氧腺 (Cordycepin,Cord) 是一种抗癌化合物,由ADA迅速失活.
通常需要同时使用ADA抑制剂才能获得Cord疗效.

研究的目的:

合成和表征一种氧化形式的Cordycepin (CordOXO).
调查CordOXO对ADA介导的除的耐药性.
探索CordOXO作为一种更稳定的抗癌剂的潜力.

主要方法:

合成7,8-二-8--3'-脱氧氨酸 (CordOXO).
使用紫外线光谱和RP-HPLC对ADA耐药性的实验评估.
对酶基质复合物的理论密度基于功能紧密结合 (DFTB) 研究.

主要成果:

由于其*syn*形状,OXO对ADA表现出显著的耐药性.
与ADA- dAdo和Cord相比,DFTB研究显示ADA和Cord^OXO之间的相互作用发生了变化.
似乎通过Cord到Cord^OXO的氧化来防止ADA的快速除.

结论:

线^OXO对ADA具有增强的稳定性,这表明治疗潜力有所改善.
这种稳定性可以在没有ADA抑制剂的情况下进行有效的癌症治疗,从而减少不良反应.
需要进一步的体外和体内研究来验证Cord^OXO的治疗效果.

关键词:

7,8-二-8--3′脱氧腺素美国氨酸脱胺酶科尔迪塞平

更多相关视频

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

相关概念视频

Allosteric Proteins-ATCase

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...